Advertisement

Medical Oncology

, Volume 26, Issue 2, pp 233–237 | Cite as

Primary extragastrointestinal stromal tumor of the transverse mesocolon without c-kit mutations but with PDGFRA mutations

  • Tadashi Terada
Case Report

Abstract

The author reports a rare case of primary large cystic extragastrointestinal stromal tumor (eGIST) of the transverse mesocolon with genetic analyses of the c-kit and platelet-derived growth factor receptor-α (PDGFRA) genes. A 78-year-old man was found to have a large cystic tumor in the abdomen, and the tumor was resected. Grossly, the tumor was located in the transverse mesocolon, and cystic. Microscopically, the tumor consisted of epithelioid cells with atypia. Mitotic figures were noted in five of 50 high power fields. Immunohistochemically, the tumor cells were positive for KIT, CD34, PDGFRA, and vimentin, but negative for cytokeratins, neuron specific enolase, desmin, S100 protein, α-smooth muscle actin, p53 protein, HMB45, CD68, CEA, factor VIII-related antigen, chromogranin, and synaptophysin. Ki67 labeling was 5%. Genetically, the tumor showed a point mutation (GAC → GTC) at codon 842 of exon 18 of the PDGFRA gene. Exon 12 of the PDGFRA gene and exons 9, 11, 13, and 17 of the c-kit gene showed no mutations. No recurrence is noted 3 years after the operation. This case shows that eGIST may occur in the transverse mesocolon.

Keywords

Transverse mesocolon eGISTs c-kit gene PDGFRA gene CD34 

References

  1. 1.
    Hirota S, Isozaki K. Pathology of gastrointestinal stromal tumor. Pathol Int. 2006;56:1–9.CrossRefPubMedGoogle Scholar
  2. 2.
    Losota J, Miettinen M. KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs). Semin Diagn Pathol. 2006;23:91–101.CrossRefGoogle Scholar
  3. 3.
    Miettinen M, Lasota J. Gastrointestinal stromal tumor: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med. 2006;130:1466–78.PubMedGoogle Scholar
  4. 4.
    Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumor. Science. 1998;279:577–80.CrossRefPubMedGoogle Scholar
  5. 5.
    Hirota S, Ohashi A, Nishida T, Isozaki K, Kinoshita K, Shinomura Y, et al. Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumor. Gastroenterology. 2003;125:660–7.CrossRefPubMedGoogle Scholar
  6. 6.
    Hu X, Forster J, Damajanov I. Primary malignant gastrointestinal stromal tumor of the liver. Arch Pathol Lab Med. 2003;127:1606–8.PubMedGoogle Scholar
  7. 7.
    Mendoza-Marin M, Hoang MP, Albores-Saavedra J. Malignant stromal tumor of the gall bladder with interstitial cells of Cajal phenotype. Arch Pathol Lab Med. 2002;126:481–2.PubMedGoogle Scholar
  8. 8.
    Ortiz-Hidalgo C, de Leon Borjorge B, Albores-Saavedra J. Stromal tumor of the gall bladder with phenotype of interstitial cells of Cajal: a previously unrecognized neoplasm. Am J Surg Pathol. 2000;24:1420–3.CrossRefPubMedGoogle Scholar
  9. 9.
    Yamaura K, Kato M, Miyazawa M, Haba Y, Muramatsu A, Miyata K, et al. Stromal tumor of the pancreas with expression of c-kit protein: report of a case. J Gastroenterol Hepatol. 2004;19:467–70.CrossRefPubMedGoogle Scholar
  10. 10.
    Daum O, Klecka J, Ferda J, Treska V, Vanecek T, Sima R, et al. Gastrointestinal stromal tumor of the pancreas: case report with documentation of KIT gene mutations. Virchows Archiv. 2005;446:470–2.CrossRefPubMedGoogle Scholar
  11. 11.
    Miettinen M, Monihan JM, Sarlomo-Rikala M, Kovatich AJ, Carr NJ, Emory TS, et al. Gastrointestinal stromal tumors/smooth muscle tumors (GISTs) primary in the omentum and mesentery: clinicopathological and immunohistochemical study of 26 cases. Am J Surg Pathol. 1999;23:1109–18.CrossRefPubMedGoogle Scholar
  12. 12.
    Jakobs K, Gheldere CD, Vanclooster P. A ruptured gastrointestinal stromal tumor of the transverse colon: a case report. Acta Chir Belg. 2006;106:218–21.Google Scholar
  13. 13.
    Paparelli C, Cavallaro G, Basso L, Polistena A, Mingazzini P, De Toma G. Giant GIST of the mesocolon, report of a case. Minerva Chir. 2006;61:537–40.PubMedGoogle Scholar
  14. 14.
    Terada T, Kawaguchi M, Furukawa K, Sekido Y, Osamura Y. Minute mixed ductal-endocrine carcinoma of the pancreas with predominant intraductal growth. Pathol Int. 2002;52:740–6.CrossRefPubMedGoogle Scholar
  15. 15.
    Terada T, Kawaguchi M. Primary clear cell adenocarcinoma of the peritoneum. Tohoku J Exp Med. 2005;271:271–5.CrossRefGoogle Scholar
  16. 16.
    Terada T (2008). Gastrointestinal stromal tumor of the uterus: a case report with genetic analyses of c-kit and PDGFRA genes. Int J Gynecol Oncol (in press).Google Scholar
  17. 17.
    Kim JH, Boo YJ, Jung CW, Park SS, Kim SJ, Mok YJ, et al. Multiple malignant extragastrointestinal stromal tumors of the greater omentum and results of immunohistochemistry and mutation analysis: a case report. World J Gastroenterol. 2007;13:3392–5.PubMedGoogle Scholar
  18. 18.
    Yamamoto H, Oda Y, Kawagichi K, Nakamura N, Takahira T, Tamiya S, et al. c-kit and PDGFRA mutations in extragastrointestinal stromal tumor (gastrointestinal stromal tumor of the soft tissue). Am J Surg Pathol. 2004;28:479–88.CrossRefPubMedGoogle Scholar
  19. 19.
    Dow N, Giblen G, Sobin LS, Miettinen M. Gastrointestinal stromal tumors: differential diagnosis. Semin Diagn Pathol. 2006;23:111–9.CrossRefPubMedGoogle Scholar
  20. 20.
    Ciontea SM, Radu E, Regalia T, Ceafalan L, Cretoiu D, Gherghiceanu M, et al. C-kit immunopositive interstitial cells (Cajal-type) in human myometrium. J Cell Mol Med. 2005;9:407–20.CrossRefPubMedGoogle Scholar
  21. 21.
    Huizinga JD, Faussone-Pellegrini MS. About the presence of interstitial cells of Cajal outside the musculature of the gastrointestinal tract. J Cell Mol Med. 2005;9:468–73.CrossRefPubMedGoogle Scholar
  22. 22.
    Hasegawa T, Matsuno Y, Shimoda T, Hirohashi S. Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB–1 grade. Hum Pathol. 2002;33:669–76.CrossRefPubMedGoogle Scholar
  23. 23.
    Sakurai S, Hishima T, Takazawa Y, Sano T, Nakajima T, Saito K, et al. Gastrointestinal stromal tumor and KIT-positive mesenchymal cells in the omentum. Pathol Int. 2001;51:524–31.CrossRefPubMedGoogle Scholar
  24. 24.
    Min KW, Leabu M. Interstitial cells of Cajal (ICC) and gastrointestinal stromal tumor (GIST): facts, speculation, and myths. J Cell Mol Med. 2006;10:995–1013.CrossRefPubMedGoogle Scholar
  25. 25.
    Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical and molecular study of 1765 cases with long-term follow-up. Am J Surg Pathol. 2005;29:52–68.CrossRefPubMedGoogle Scholar
  26. 26.
    Singer S, Rubin BP, Lux ML, Chen CJ, Demetri GD, Fletcher JA. Prognostic value of KIT mutation type, mitotic activity and histological subtype in gastrointestinal stromal tumor. J Clin Oncol. 2002;20:3898–905.CrossRefPubMedGoogle Scholar

Copyright information

© Humana Press Inc. 2008

Authors and Affiliations

  1. 1.Department of PathologyShizuoka Municipal Shimizu HospitalShizuokaJapan

Personalised recommendations